 |
05 June 2002,
Wednesday
10.30
- 11.00
Session 2.1
Design
and Construction of Genentech's Founders Research Center II:
Complexities of Leading Design-Construction Projects of
Bio-Technology Laboratory Projects
Melody A
Spradlin
Genentech Inc
Dr John Kunz
Stanford
University
USA
11.15 - 11.45
Session 2.2
Decision Finding in the
Innovation Process
Dr Juergen Henrich
Aventis CropScience,
Germany
13.15 - 13.45
Session 2.3
From Strategy to Program and
Program to Project: Critical Links
Dr Francis
Hartman
SMART Management Inc., Canada
14.00 - 14.30
Session 2.4
Project Portfolio Management
(PPM) as a means to understand important systemic connections
between biotech projects
Taina Ikonen
Prof Karlos A.
Artto
Helsinki University of Technology
Finland
15.00 - 15.30
Session 2.5
The Design and Implementation of
Project Management Processes in a Small Chemical Company
Dr
Denise Ann Bower
Prof Nigel Smith
Ed Fish
The University of
Leeds, UK
15.45 - 16.15
Session 2.6
Time to market for
Pharmaceuticals. A rational approach to balance Time, Money and
Risk
Emile Burnaby Lautier
Project Services
Netherlands
|
 |
13.15 - 13.45
Session
2.7
Development of competences as a project oriented
company. A case study in the chemical industry
Mag Michael
Stummer
Roland Gareis Consulting
Dr Martina Huemann
Project
Management Group
Austria
14.00 - 14.30
Session 2.8
How to boost productivity
through web enabled project resource management for pharmaceutical
companies
Harald Geimer
Bob Eslampour
PRTM Pittiglio
Rabin Todd & McGrath, UK
15.00 - 15.30
Session 2.9
A complexity analysis model for
management of Good Manufacturing Practice and ISO 9000-2001
compliancy simultaneous projects. Case study in the pharmaceutical
industry.
Massimo De Falco
University of Lecce
Maria
Elena Nenni
University of Naples
Massimiliano M.
Schiraldi
University of Rome
Italy
15.45 - 16.15
Session 2.10
Co-developments of 2 different
BioTechnology products
Gillis Ponterius
Pharmacia
Diagnostics AB, Sweden
|
